Answers are grounded in this paper and cite their sources.
< .05). Differences in survival did not correlate with genetic profile or extent of therapy. HLH should be conceptualized as a phenotype of critical illness characterized by toxic activation of immune cells from different underlying mechanisms. In most patients with HLH, targeted sequencing of fHLH genes remains insufficient for identifying pathogenic mechanisms. Whole-exome sequencing, however, may identify specific therapeutic opportunities and affect hematopoietic stem cell transplantation options for these patients.
No takes yet. Share an insight, caveat, or question.
Chinn et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: